Latest Breaking News On - Josh brodsky - Page 1 : comparemela.com

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension

CAMBRIDGE, Mass. (BUSINESS WIRE) Apr 7, 2024

United kingdomUnited statesChristine regan lindenboomJosh brodskyAkshay desaiSimon foxAlnylam pharmaceuticalsHealth promotion seriesZilebesiran program lead at alnylamWorld health organizationJournal of the american college cardiologySecurities exchangeAmerican college of cardiologyExchange commissionAlnylam pharmaceuticals nasdaqHeart failure program

Alnylam Pharmaceuticals, Inc : Alnylam to Webcast Presentations at Upcoming November Investor Conferences

Alnylam Pharmaceuticals, Inc : Alnylam to Webcast Presentations at Upcoming November Investor Conferences
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomNew yorkUnited statesCity ofChristine regan lindenboomJosh brodskyPiper sandlerAlnylam pharmaceuticalsAlnylam pharmaceuticals incLotte new york palace hotelAlnylam pharmaceuticals nasdaqLondon healthcare conferenceNew york cityAnnual healthcare conferenceNobel prize winningRegan lindenboom

Alnylam Recognized by Science Magazine as Top Employer for Fifth Consecutive Year

Alnylam Recognized by Science Magazine as Top Employer for Fifth Consecutive Year
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesChristine regan lindenboomKevin fitzgeraldJosh brodskyAlnylam pharmaceuticals incTop employerAlnylam pharmaceuticals nasdaqAlnylam pharmaceuticalsAnnual surveyRanked alnylamTop threeBest employers list sinceTop employer surveyChief scientificNorth america

Alnylam Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine

Alnylam Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomChristine regan lindenboomJosh brodskyMathew maurerPushkal gargDrug administrationHealth statusAlnylam pharmaceuticals incHeart failure society of americaAlnylam pharmaceuticals nasdaqAlnylam pharmaceuticalsSecurities exchangeExchange commissionEuropean unionTherapeutic preserved functional capacity

Alnylam Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental New Drug Application for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis

CAMBRIDGE, Mass. (BUSINESS WIRE) Sep 13, 2023

United kingdomUnited statesJosh brodskyEuropean unionExchange commissionAlnylam pharmaceuticals nasdaqRenal drugs advisory committeeAdvisory committeeSecurities exchangeAlnylam pharmaceuticals inc christine regan lindenboomAlnylam pharmaceuticals incDrug administrationAlnylam pharmaceuticalsNew drug applicationPrescription drug user feeImportant safety